BRIEF-U.S. FDA approves Pfizer's leukemia drug Besponsa
August 17, 2017 at 13:40 PM EDT
* U.S. FDA approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia
